Navigation Links
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
Date:6/17/2008

ical testosterone gel approved in 2000 for replacement therapy in men ages 18 and older for conditions associated with a deficiency or absence of endogenous testosterone. AndroGel is the most prescribed form of testosterone therapy for adult males in the United States.

Pivotal data showed that AndroGel was effective in restoring testosterone levels to normal and in some cases, superior to a transdermal testosterone patch.

-- AndroGel was effective in improving sexual function, mood, and muscle

strength; increasing lean body mass; and decreasing body fat.

-- It was demonstrated that AndroGel was more effective than a

testosterone patch in increasing lean body mass and decreasing body

fat, and had comparable effects with other symptoms.

-- Because of minimal skin irritation, subjects using AndroGel also had

higher compliance rates.

-- In a 2004 open-label, follow-up extension study, AndroGel was shown to

be safe for men to use over the long term.

The AndroGel pump is designed to deliver 1.25 grams of testosterone gel per pump depression, and it is also available in 2.5 and 5 gram packets. This gives patients two convenient ways to use AndroGel and offers physicians added flexibility to move, if necessary, from the starting dose of 5g per day to 7.5g or from 7.5g to 10g per day.

AndroGel must not be used if you have known or suspected prostate cancer or breast cancer (a rare condition for men). AndroGel must not be used by women who are pregnant, may become pregnant, or breastfeeding, as testosterone may cause fetal harm. The major risks of AndroGel include prostate enlargement, prostate cancer, and transfer of testosterone to others (including women and children). Transference can occur when vigorous skin-to- skin contact is made with the application site and can be minimized by washing your hands after application and covering the application site with clothing.

T
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
6. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
7. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
8. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
9. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
10. Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients
11. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...tCall/ -- Cardiac Science Corporation (Nasdaq:...fibrillator ( AED ) and diagnostic cardiac monit...llion for the third quarter ended September 30, 20...y also recorded a charge of $18.5 million for an A...44.0 million to increase its valuation allowance a...
(Date:11/9/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...8th annual Global Congress for Minimally Invasive ...in Orlando, Florida. Results from two clinical st...ology/Gynecology products, including pelvic floor ...ems used to treat pelvic floor vaginal wall prolap...
(Date:11/9/2009)...Newswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: ...xth Annual Lazard Capital Markets Healthcare Confe... Hotel in New York City (November 17-19, 2009). ,...ef Executive Officer, will provide an overview of ...5 PM (ET). ,, To access a simultaneous webcast ...
Breaking Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3New Cases of Alzheimers and Dementia Continue to Rise Even in the Oldest Old 51413 1New Cases of Alzheimers and Dementia Continue to Rise Even in the Oldest Old 51413 2New Cases of Alzheimers and Dementia Continue to Rise Even in the Oldest Old 51413 3New Cases of Alzheimers and Dementia Continue to Rise Even in the Oldest Old 51413 4New cases of Alzheimers and dementia continue to rise even in the oldest old 51412 1New cases of Alzheimers and dementia continue to rise even in the oldest old 51412 2New cases of Alzheimers and dementia continue to rise even in the oldest old 51412 3News from Cancer 51410 1News from Cancer 51410 2News from Cancer 51410 3News from Cancer 51410 4
...afety data were generally consistent with oral ola...n-related events, VENICE, Italy, June 23 Results...cal trials showed that the,efficacy and safety pro...th,that of Zyprexa(R) (olanzapine) with the except...-week maintenance study (HGKA) and interim,finding...
...e available on NCI Database Could Save Drug Develo...arch Institutions, PHILADELPHIA, June 20 Marking...against cancer, GlaxoSmithKline,(NYSE: GSK ) anno...for over,300 cancer cell lines via the National Ca...aBIG(TM)). The caBIG(TM) initiative is a network,o...
Other Medicine Technology:Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 2Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 3Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 4Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 5Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 6Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 7Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 8GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers 2GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers 3
(Date:11/9/2009)...HINGTON, Nov. 9 The Churchill Ce...ward For Leadership to J.W. "Bill" Marriott for hi...gh progressive free market practices and fostering...Mr. Marriott will receive his award at a ceremony ...on D.C. Four Seasons Hotel. ,, "This is a test...
(Date:11/9/2009)...lped men and women almost equally, study finds, ,...e widely used clot-dissolving drug Plavix (clopido...analysis of major clinical trials has found. , ...n treating both men and women with this very impor...f cardiovascular thrombosis at New York University...
(Date:11/9/2009)...n of plans finds differences in mood despite simil...hDay News) -- Both a high-fat, low-carbohydrate di...t, high-carb diet appear to help people lose pound...? Only the low-fat diets will result in long-term ...ov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it ...ion, according to TOPS Club, Inc. (Take Off Pounds...nization. , (Vocus) Novem...mes to preventing or improving a diabetes conditio...ensibly), the nonprofit weight-loss support organi...
(Date:11/9/2009)...ANON, Tenn., Nov. 9 Health Connect...ced it will host their inaugural Hospital O.R. and...at the Marriott Renaissance Hotel in Nashville, Te...e than 100 hospital operating room directors and m...lth systems in the country. Some of the confirmed ...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...tra El Cancer, an,organization dedicated to improv...ancer and their families, will host its Annual Hol...ients this Saturday, December 13, 2008. , Ch...ebrating holiday traditions. In addition to the s...
...Vital Images, Inc. (Nasdaq: VTAL ) , a leadin...on and analysis solutions, has named Ray A. Ghanba...d Products, a new position at ViTAL. Ghanbari repo...elopment and driving strategic business planning. ...
... this,afternoon by some major Michigan newspapers,...rmation about Executive Order (EO) budget cuts pro...y, the stories mistakenly reported:,"Another $5.3 ...ealth care treatment delivered to Medicaid patient...
...ER treatment, elective procedures, study says , ...re could be a shortage of 1,300 general surgeons i...at shortage could increase to 6,000 by 2050, a new...ency departments. A shortage of general surgeons m...
...consecutive year,hundreds of Conseco employees in ...eer for the needy of central Indiana as part of th...oliday season, Conseco partners with the United Ch...volunteers often add their,own donations and perfo...
...ernacional,S.A.B. de C.V. (BMV: LAB) ("Genomma Lab...unter ("OTC") pharmaceuticals and personal care pr...uidance. The Company expects to reach,organic gro...sed on the organic growth of core products (produc...
Other Medicine News:Health News:PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer 2Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 2Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 3Health News:U.S. May Soon Face Shortage of General Surgeons 2Health News:Conseco Employees Provide Holiday Cheer for 40 Central Indiana Families 2Health News:Genomma Lab Announces 2009 Earnings Guidance 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: